Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction.
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2018
At a glance
- Drugs Recombinant erythropoietin (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 12 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2006 New trial record.